JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 8, 2007; DOI: 10.1124/jpet.107.120519


0022-3565/07/3213-975-982$20.00
JPET 321:975-982, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.120519v1
321/3/975    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Preuss, H.
Right arrow Articles by Seifert, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Preuss, H.
Right arrow Articles by Seifert, R.

CELLULAR AND MOLECULAR

Mutations of Cys-17 and Ala-271 in the Human Histamine H2 Receptor Determine the Species Selectivity of Guanidine-Type Agonists and Increase Constitutive Activity

Hendrik Preuss, Prasanta Ghorai1, Anja Kraus, Stefan Dove, Armin Buschauer, and Roland Seifert

Departments of Pharmaceutical/Medicinal Chemistry II (H.P., P.G., A.K., S.D., A.B.) and Pharmacology and Toxicology (R.S.), Institute of Pharmacy, University of Regensburg, Regensburg, Germany

In a steady-state GTPase activity assay, N-[3-(1H-imidazol-4-yl)propyl)]guanidines and NG-acylated derivatives are more potent and efficacious at fusion proteins of guinea pig (gpH2R-Gs{alpha}S) than human (hH2R-Gs{alpha}S) histamine H2 receptor, coupled to the short splice variant of Gs{alpha}, Gs{alpha}S. Whereas Ala-271 (hH2R) and Asp-271 (gpH2R) in transmembrane domain 7 were identified to determine the potency differences of guanidine-type agonists, the molecular basis for the efficacy differences remains to be elucidated. A homology model of the gpH2R suggested that an H-bond between Tyr-17 and Asp-271 stabilizes an active receptor conformation of the gpH2R. In the present study, we generated a mutant hH2R-Gs{alpha}S with Cys-17-> Tyr-17/Ala-271-> Asp-271 exchanges (hH2R->gpH2R) that exhibited an enhanced level of constitutive GTPase activity and adenylyl cyclase activity compared with wild-type hH2R-Gs{alpha}S and gpH2R-Gs{alpha}S. Potencies and efficacies of guanidines and NG-acylguanidines were increased at this mutant receptor compared with hH2R-Gs{alpha}S, but they were still lower than at gpH2R-Gs{alpha}S, suggesting that aside from Tyr-17 and Asp-271 additional amino acids contribute to the distinct pharmacological profiles of both species isoforms. Another hH2R-Gs{alpha}S mutant with a Cys-17-> Tyr-17 exchange showed inefficient coupling to Gs{alpha}S as revealed by reduced agonist-stimulated GTPase and basal adenylyl cyclase activities. Collectively, our present pharmacological study confirms the existence of an H-bond between Tyr-17 and Asp-271 favoring the stabilization of an active receptor conformation. Distinct potencies and efficacies of agonists and inverse agonists further support the concept of ligand-specific conformations in wild-type and mutant H2R-Gs{alpha}S fusion proteins.


Received for publication January 25, 2007
Accepted March 2, 2007.

Address correspondence to: Dr. Roland Seifert, Department of Pharmacology and Toxicology, University of Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany. E-mail: roland.seifert{at}chemie.uni-regensburg.de




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Strasser, H.-J. Wittmann, M. Kunze, S. Elz, and R. Seifert
Molecular Basis for the Selective Interaction of Synthetic Agonists with the Human Histamine H1-Receptor Compared with the Guinea Pig H1-Receptor
Mol. Pharmacol., March 1, 2009; 75(3): 454 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Preuss, P. Ghorai, A. Kraus, S. Dove, A. Buschauer, and R. Seifert
Constitutive Activity and Ligand Selectivity of Human, Guinea Pig, Rat, and Canine Histamine H2 Receptors
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 983 - 995.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.